Nycomed Amersham received the Queen’s Award for Enterprise, which is given in recognition for a company’s outstanding achievement in technology, exports, or environmental performance. Queen Elizabeth grants the awards on her April 21st
Nycomed Amersham received the Queens Award for Enterprise, which is given in recognition for a companys outstanding achievement in technology, exports, or environmental performance. Queen Elizabeth grants the awards on her April 21st birthday.
The companys headquarters are located in the U.K. while its North American operations are headquartered in Princeton, NJ.
The companys U.K. imaging business group won the award for its continuous achievement in export sales from 1994 to 1999. During this time, Nycomeds British exports more than doubled. Over half of Nycomeds success came through sales from the U.S. office. Myoview, a heart imaging agent, and OncoSeed, a treatment for prostate cancer, were best-sellers, said Daniel L. Peters, Nycomed Imagings U.S. president. The company has won the Queens Award 14 times in the last 33 years.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.